The tenth Session of the Codex Committee on Residues of Veterinary Drugs in Foods reached the following conclusions:
|
MATTERS FOR CONSIDERATION BY THE CODEX ALIMENTARIUS COMMISSION: - Advanced draft maximum residue limits for Carazolol (pig muscle, fat/skin, liver and kidney); Diminazine (cattle muscle, liver, kidney and milk); Doramectin (cattle muscle, liver, kidney and fat); Levamisole (poultry liver; cattle/pig/sheep/poultry muscle, kidney and fat); Moxidectin (cattle/sheep muscle, liver, kidney and fat); Spiramycin (cattle/pigs/chicken) muscle, liver, kidney and fat; and cattle milk), and; Triclabendazole (cattle/sheep fat) to the Commission for adoption at Step 8 (paras. 22, 24-31 and Appendix II); - Advanced proposed draft maximum residue limits for Oxytetracycline (giant prawn), Moxidectin (deer muscle, liver, kidney and fat) and Spiramycin (pig liver, kidney and fat) to the Commission for adoption at Steps 5/8 (paras. 38, 47, 50 and Appendix IV); - Advanced proposed draft maximum residue limits for Abamectin, Azaperone, Chlorotetracycline/Oxytetracycline/Tetracycline, Cypermethrin, a-Cypermethrin, Dexamethasone, Diclazuril, Dihydrostreptomycin/Streptomycin, Febantel/ Febendazole/ Oxfendazole, Gentamicin, Neomycin, Spectinomycin, Thiamphenicol and Tilmicosin to the Commission for adoption at Step 5 (paras. 35-37, 40-46, 48-49, 51-52 and Appendix V); - Recommended that a discussion paper concerning the Review of Performance-based Criteria for Methods of Analysis and Sampling be referred to the Codex Committee on Methods of Analysis and Sampling and brought to the attention of the Codex Committees on Pesticide Residues, Food Additives and Contaminants and Food Hygiene in view of its important implications; requested that the paper be revised and circulated for comment prior to the Committee's next session (para. 61); - Agreed to Amendments to Methods of Analysis for Previously Adopted Maximum Residue Limits for Veterinary Drugs (para. 62 and Appendix VIII), and; - Agreed on a Priority List of Veterinary Drugs Requiring Evaluation or Reevaluation (ALINORM 97/31A, para. 75). OTHER MATTERS OF INTEREST TO THE COMMISSION - Agreed to refer its main findings concerning Risk Assessment in the Codex Committee on Residues of Veterinary Drugs in Foods to the Commission, and to circulate a revised paper on the subject for comment subsequent to the Commission's discussions (para. 12); - Welcomed the presentation of a Progress Report on International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products at its next session (para. 20); - Retained draft maximum residue limits for Ceftiofur (cattle/pigs muscle, liver, kidney and fat; cattle milk) at Step 7 (para. 23 and Appendix III); - Retained proposed draft maximum residue limits for Clenbuterol (cattle/horses muscle, liver, kidney and fat; cattle milk) at Step 4 (para. 39 and Appendix VI); - Invited JECFA to examine issues raised in the document concerning Guidelines on Residues at Injection Sites and requested that the paper be revised and circulated for comment prior to its next Session (para. 56); - Requested that the document concerning the Review of Codex Guidelines for the Establishment of a Regulatory Programme for Control of Veterinary Drug Residues in Milk and Milk Products be revised and circulated for comment prior to its next Session (para. 66); - Agreed not to pursue the development of any recommendations contained in the document concerning Residue Management Initiatives in Codex (para. 69); - Agreed that future Progress Reports on the Compendium of Veterinary Drugs be discussed under Other Business when required (para. 78), and; - Noted a request for attention to be given to data
requirements for the establishment of MRLs for Minor Species (para. 79).
|
